← Back to Analyst Consensus 
INSM Buy
INSMED Inc
Current Price —
Implied Upside —
Analysts 31
30-Day Momentum
▲ 0 upgrades / ▼ 1 downgrades / 3 reiterations from 4 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $213 | 54% |
| Oct 12, 2026 | Wolfe Research | downgrade | Outperform → Peer Perform | $0 | 53% |
| Oct 12, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $220 | 44% |
| Sep 30, 2026 | Barclays | maintain | Overweight → Overweight | $207 | 53% |
| Sep 15, 2026 | Roth Capital | reiterate | Buy → Buy | $198 | 53% |
| Aug 10, 2026 | JP Morgan | maintain | Overweight → Overweight | $175 | 55% |
| Aug 10, 2026 | Truist Securities | reiterate | Buy → Buy | $195 | 54% |
| Aug 7, 2026 | Guggenheim | maintain | Buy → Buy | $205 | 52% |
| Aug 7, 2026 | Wells Fargo | maintain | Overweight → Overweight | $169 | 54% |
| Aug 7, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $170 | 58% |
| Jul 21, 2026 | BMO Capital | initiate | — → Outperform | $192 | 53% |
| Jul 15, 2026 | Wells Fargo | maintain | Overweight → Overweight | $161 | 54% |
| Jul 10, 2026 | Guggenheim | reiterate | Buy → Buy | $207 | 52% |
| Jun 22, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $160 | 58% |
| Jun 8, 2026 | JP Morgan | maintain | Overweight → Overweight | $179 | 55% |
| Jun 5, 2026 | RBC Capital | maintain | Outperform → Outperform | $195 | 55% |
| May 14, 2026 | Truist Securities | maintain | Buy → Buy | $185 | 54% |
| May 8, 2026 | RBC Capital | maintain | Outperform → Outperform | $205 | 55% |
| May 8, 2026 | Wells Fargo | maintain | Overweight → Overweight | $160 | 54% |
| May 8, 2026 | Guggenheim | maintain | Buy → Buy | $226 | 52% |
| Apr 17, 2026 | Roth Capital | reiterate | Buy → Buy | $212 | 53% |
| Apr 14, 2026 | RBC Capital | maintain | Outperform → Outperform | $216 | 55% |
| Apr 1, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Mar 30, 2026 | Morgan Stanley | upgrade | Equal-Weight → Overweight | — | 54% |
| Mar 26, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 25, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Mar 24, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| Mar 24, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Mar 24, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Mar 24, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Mar 23, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Feb 24, 2026 | Mizuho | maintain | Outperform → Outperform | $204 | 52% |
| Feb 23, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $230 | 44% |
| Feb 20, 2026 | Wells Fargo | maintain | Overweight → Overweight | $208 | 54% |
| Jan 30, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $162 | 54% |
| Jan 28, 2026 | Barclays | initiate | — → Overweight | $231 | 53% |
| Jan 23, 2026 | Roth Capital | initiate | — → Buy | $212 | 53% |
| Jan 21, 2026 | RBC Capital | maintain | Outperform → Outperform | $200 | 55% |
| Jan 6, 2026 | UBS | maintain | Buy → Buy | $215 | 54% |
| Dec 18, 2025 | TD Cowen | maintain | Buy → Buy | $241 | 54% |
| Dec 18, 2025 | Goldman Sachs | maintain | Buy → Buy | $225 | 54% |
| Dec 18, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $230 | 44% |
| Dec 18, 2025 | Guggenheim | maintain | Buy → Buy | $221 | 52% |
| Dec 18, 2025 | RBC Capital | maintain | Outperform → Outperform | $195 | 55% |
| Dec 16, 2025 | Wells Fargo | maintain | Overweight → Overweight | $234 | 54% |
| Dec 16, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $230 | 50% |
| Dec 15, 2025 | Goldman Sachs | maintain | Buy → Buy | $258 | 54% |
| Dec 11, 2025 | TD Cowen | maintain | Buy → Buy | $269 | 54% |
| Dec 1, 2025 | Mizuho | maintain | Outperform → Outperform | $256 | 52% |
| Nov 20, 2025 | TD Cowen | maintain | Buy → Buy | $231 | 54% |
Price Target Trend
Jul 31, 2026 Oct 26, 2026
EPS Estimates
0y —
0q —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days